Status:
COMPLETED
Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Anal Canal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting \[low dose rate (LDR) and high dose rate (HDR)\]
Detailed Description
Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate, Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.
Eligibility Criteria
Inclusion
- Patients treated by brachytherapy anal canal to boost.
Exclusion
- Patients below age of 18 years
Key Trial Info
Start Date :
August 17 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 28 2016
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03465501
Start Date
August 17 2007
End Date
July 28 2016
Last Update
March 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli Calmettes
Marseille, Bouches Du Rhone, France, 13009